Medical Innovations, LLC (USMI), a U.S. FDA-registered life
science, biomedical and robotic-device company (a subsidiary of US
Patent Innovations, LLC), announced today that Jerome Canady MD, Chief
Executive Officer, USMI, will be presenting “Cold Plasma
Oncotherapeutics™ and Robotic Voice-Operated Delivery System. The Future
of Cancer Treatment” at the JMP Securities Life Sciences Conference
Wednesday, June 19, 2019, 1:00 PM at the St. Regis Hotel New York, NY.
A live audio webcast of the conference presentation will be available
online at http://wsw.com/webcast/jmp39/umi/
or through the company’s website at www.usmedinnovations.com/media-center/upcoming-events/.
A replay of the webcast will be archived on the website for
approximately 90 days.
About US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a
privately-held FDA-registered life science, biomedical and
robotic-device company. USMI is dedicated to expanding the boundaries of
plasma medicine for the treatment of cancer and pioneering new surgical
and robotic technologies that advance patient outcomes and improve human